Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype
- PMID: 9773787
- DOI: 10.1681/ASN.V9101861
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype
Abstract
X-linked nephrogenic diabetes insipidus (NDI) is a rare disease with defective renal and extrarenal arginine vasopressin V2 receptor responses due to mutations in the AVPR2 gene in Xq28. To study the cause of loss of function of mutant V2 receptors, we expressed 12 mutations (N55H, L59P, L83Q, V88M, 497CC-->GG, deltaR202, I209F, 700delC, 908insT, A294P, P322H, P322S) in COS-7 cells. Eleven of these, including P322H, were characterized by a complete loss of function, but the mutation P322S demonstrated a mild clinical and in vitro phenotype. This was characterized by a late diagnosis without any growth or developmental delay and a significant increase in urine osmolality after intravenous 1-deamino[D-Arg8]AVP administration. In vitro, the P322S mutant was able to partially activate the Gs/adenylyl cyclase system in contrast to the other V2R mutants including P322H, which were completely inactive in this regard. This showed not only that Pro 322 is important for proper V2R coupling, but also that the degree of impairment is strongly dependent on the identity of the substituting amino acid. Three-dimensional modeling of the P322H and P322S mutant receptors suggested that the complete loss of function of the P322H receptor could be due, in part, to hydrogen bond formation between the His 322 side chain and the carboxyl group of Asp 85, which does not occur in the P322S receptor.
Similar articles
-
Functional study of two V2 vasopressin mutant receptors related to NDI. P322S and P322H.Adv Exp Med Biol. 1998;449:391-3. doi: 10.1007/978-1-4615-4871-3_50. Adv Exp Med Biol. 1998. PMID: 10026830 No abstract available.
-
Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.J Am Soc Nephrol. 1997 Dec;8(12):1855-62. doi: 10.1681/ASN.V8121855. J Am Soc Nephrol. 1997. PMID: 9402087
-
Vasopressin receptor mutations causing nephrogenic diabetes insipidus.Proc Assoc Am Physicians. 1998 Sep-Oct;110(5):387-94. Proc Assoc Am Physicians. 1998. PMID: 9756088 Review.
-
Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.Mol Endocrinol. 1997 Nov;11(12):1806-13. doi: 10.1210/mend.11.12.0017. Mol Endocrinol. 1997. PMID: 9369448
-
Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.Metabolism. 2012 Jul;61(7):922-30. doi: 10.1016/j.metabol.2012.01.005. Epub 2012 Mar 3. Metabolism. 2012. PMID: 22386940 Review.
Cited by
-
Aquaporins in Diabetes Insipidus.Adv Exp Med Biol. 2023;1398:267-279. doi: 10.1007/978-981-19-7415-1_18. Adv Exp Med Biol. 2023. PMID: 36717500
-
Culturing primary rat inner medullary collecting duct cells.J Vis Exp. 2013 Jun 21;(76):50366. doi: 10.3791/50366. J Vis Exp. 2013. PMID: 23852264 Free PMC article.
-
Class A and C GPCR Dimers in Neurodegenerative Diseases.Curr Neuropharmacol. 2022;20(11):2081-2141. doi: 10.2174/1570159X20666220327221830. Curr Neuropharmacol. 2022. PMID: 35339177 Free PMC article. Review.
-
Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.Eur J Pediatr. 2015 Oct;174(10):1373-85. doi: 10.1007/s00431-015-2534-4. Epub 2015 Apr 23. Eur J Pediatr. 2015. PMID: 25902753
-
How genetic errors in GPCRs affect their function: Possible therapeutic strategies.Genes Dis. 2015 Jun;2(2):108-132. doi: 10.1016/j.gendis.2015.02.005. Genes Dis. 2015. PMID: 26229975 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous